Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.91
(0.18%)
CNY 16.91
(0.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.94 Billion CNY | 7.61% |
| 2022 | 1.8 Billion CNY | 23.86% |
| 2021 | 1.45 Billion CNY | 33.6% |
| 2020 | 1.09 Billion CNY | 19.72% |
| 2019 | 911.16 Million CNY | 24.77% |
| 2018 | 730.26 Million CNY | -8.02% |
| 2017 | 793.91 Million CNY | -5.49% |
| 2016 | 840.03 Million CNY | 25.22% |
| 2015 | 670.85 Million CNY | 30.28% |
| 2014 | 514.92 Million CNY | 22.77% |
| 2013 | 419.41 Million CNY | 22.01% |
| 2012 | 343.75 Million CNY | 23.07% |
| 2011 | 279.32 Million CNY | 6.35% |
| 2010 | 262.65 Million CNY | 21.97% |
| 2009 | 215.34 Million CNY | 30.59% |
| 2008 | 164.9 Million CNY | 30.27% |
| 2007 | 126.58 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 744.28 Million CNY | 10.61% |
| 2024 Q3 | 616.62 Million CNY | -17.15% |
| 2024 Q1 | 672.89 Million CNY | 40.91% |
| 2023 Q1 | 495.69 Million CNY | 7.58% |
| 2023 Q4 | 477.54 Million CNY | 5.3% |
| 2023 Q3 | 453.48 Million CNY | -12.07% |
| 2023 Q2 | 515.76 Million CNY | 4.05% |
| 2023 FY | 1.94 Billion CNY | 7.61% |
| 2022 Q1 | 439.41 Million CNY | 15.96% |
| 2022 FY | 1.8 Billion CNY | 23.86% |
| 2022 Q4 | 460.75 Million CNY | 2.51% |
| 2022 Q3 | 449.45 Million CNY | -1.33% |
| 2022 Q2 | 455.53 Million CNY | 3.67% |
| 2021 FY | 1.45 Billion CNY | 33.6% |
| 2021 Q4 | 378.92 Million CNY | -0.49% |
| 2021 Q3 | 380.79 Million CNY | 6.51% |
| 2021 Q2 | 357.51 Million CNY | 5.1% |
| 2021 Q1 | 340.15 Million CNY | 5.86% |
| 2020 FY | 1.09 Billion CNY | 19.72% |
| 2020 Q3 | 302.76 Million CNY | 10.66% |
| 2020 Q1 | 193.18 Million CNY | -24.05% |
| 2020 Q2 | 273.6 Million CNY | 41.62% |
| 2020 Q4 | 321.32 Million CNY | 6.13% |
| 2019 Q2 | 225.14 Million CNY | 10.69% |
| 2019 FY | 911.16 Million CNY | 24.77% |
| 2019 Q3 | 228.26 Million CNY | 1.38% |
| 2019 Q4 | 254.35 Million CNY | 11.43% |
| 2019 Q1 | 203.39 Million CNY | 0.84% |
| 2018 Q3 | 136.68 Million CNY | -38.5% |
| 2018 FY | 730.26 Million CNY | -8.02% |
| 2018 Q2 | 222.27 Million CNY | 31.06% |
| 2018 Q4 | 201.7 Million CNY | 47.57% |
| 2018 Q1 | 169.59 Million CNY | -13.0% |
| 2017 Q4 | 194.94 Million CNY | 23.8% |
| 2017 Q3 | 157.47 Million CNY | -34.42% |
| 2017 Q1 | 201.37 Million CNY | -1.9% |
| 2017 FY | 793.91 Million CNY | -5.49% |
| 2017 Q2 | 240.11 Million CNY | 19.24% |
| 2016 Q2 | 256.06 Million CNY | 21.04% |
| 2016 FY | 840.03 Million CNY | 25.22% |
| 2016 Q4 | 205.28 Million CNY | 22.83% |
| 2016 Q1 | 211.56 Million CNY | 15.0% |
| 2016 Q3 | 167.12 Million CNY | -34.74% |
| 2015 Q4 | 183.97 Million CNY | 16.45% |
| 2015 FY | 670.85 Million CNY | 30.28% |
| 2015 Q3 | 157.98 Million CNY | -5.33% |
| 2015 Q2 | 166.88 Million CNY | 3.01% |
| 2015 Q1 | 162.01 Million CNY | -4.63% |
| 2014 Q4 | 169.88 Million CNY | 39.94% |
| 2014 Q3 | 121.39 Million CNY | 2.07% |
| 2014 FY | 514.92 Million CNY | 22.77% |
| 2014 Q1 | 104.71 Million CNY | -6.63% |
| 2014 Q2 | 118.93 Million CNY | 13.58% |
| 2013 Q4 | 112.14 Million CNY | 7.98% |
| 2013 FY | 419.41 Million CNY | 22.01% |
| 2013 Q3 | 103.86 Million CNY | -5.76% |
| 2013 Q2 | 110.2 Million CNY | 18.24% |
| 2013 Q1 | 93.2 Million CNY | -0.18% |
| 2012 Q4 | 93.37 Million CNY | 2.78% |
| 2012 Q3 | 90.84 Million CNY | 7.79% |
| 2012 Q2 | 84.27 Million CNY | 11.99% |
| 2012 FY | 343.75 Million CNY | 23.07% |
| 2012 Q1 | 75.25 Million CNY | -7.13% |
| 2011 Q3 | 71.6 Million CNY | -5.34% |
| 2011 Q1 | 51.05 Million CNY | -32.55% |
| 2011 Q2 | 75.64 Million CNY | 48.16% |
| 2011 Q4 | 81.03 Million CNY | 13.18% |
| 2011 FY | 279.32 Million CNY | 6.35% |
| 2010 FY | 262.65 Million CNY | 21.97% |
| 2010 Q4 | 75.68 Million CNY | 10.83% |
| 2010 Q2 | 77.49 Million CNY | 88.13% |
| 2010 Q3 | 68.29 Million CNY | -11.87% |
| 2010 Q1 | 41.18 Million CNY | 0.0% |
| 2009 FY | 215.34 Million CNY | 30.59% |
| 2008 FY | 164.9 Million CNY | 30.27% |
| 2007 FY | 126.58 Million CNY | 0.0% |